Skip to main content

Table 5 Assessment of the selectivity for the suggested method in the presence of some common excipients

From: Nano-level assay of attention-deficit/hyperactivity disorder medicament, atomoxetine by molecular-size-based resonance rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis

Excipients

Amount added

(µg mL− 1)

Drug con. (ng mL− 1)

% Recovery ± SDa

Mg stearate

10

550

100.53 ± 1.02

Starch

50

550

101.69 ± 0.62

Lactose

10

550

99.15 ± 0.90

Glucose

10

550

98.43 ± 1.56

Talc

5

550

98.35 ± 0.82

Sorbitol

10

550

99.21 ± 1.16

Macrogol (PEG 400)

30

550

101.02 ± 1.62

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us